News & Publications

News

Presentations at HIV Research for Prevention 17-21 October 2016: hivr4p.org

Oral presentation: Comparing Different Priming Strategies to Optimize HIV Vaccine Antibody Responses: Results from HVTN 096/EV04 (NCT01799954)

<< Prev
Next >>

Our latest press release

27 January 2016
Launch of the EHVA consortia funded by the EU H2020 program

The European HIV Vaccine Alliance (EHVA) is a project funded by EU H2020 program. Its primary objective is to develop a multidisciplinary platform to evaluate novel preventive and therapeutic vaccines. EuroVacc provides the support in the scientific project management.
Read press release: English French

See al our press releases

Our latest scientific publications

Asbach B et al.
Streamlining Heterologous DNA-Prime and NYVAC/Protein-Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.Journal of Virology. Feb 2016

Obuku AE et al.
Effect of Schistosoma mansoni infection on innate and HIV-1 specific T cell immune responses in HIV-1 infected Ugandan fisher folk. AIDS Res Hum Retroviruses. Feb 2016

See all our scientific publications